Mirtazapine Therapy for Posttraumatic Stress Disorder: Implications of Alpha-Adrenergic Pharmacology on the Startle Response

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Harvard Review of Psychiatry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/HRP.0000000000000173PMID 29303920
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacology for sleep disturbance in PTSD

  2016influential reference
• PSYCHOTHERAPY VERSUS PHARMACOTHERAPY FOR POSTTRAUMATIC STRESS DISORDER: SYSTEMIC REVIEW AND META‐ANALYSES TO DETERMINE FIRST‐LINE TREATMENTS

  2016cited by this paper
• COMBINED MIRTAZAPINE AND SSRI TREATMENT OF PTSD: A PLACEBO‐CONTROLLED TRIAL

  2015cited by this paper
• Post-traumatic stress disorder in veterans of Operation Enduring Freedom/Operation Iraqi Freedom: Retrospective review of treatment received compared to evidence-based practice guidelines

  2014cited by this paper
• α2-Adrenoceptors are targets for antipsychotic drugs

  2014influential reference
• Clinician's Guide to Medications for PTSD

  2014influential reference
• Posttraumatic stress disorder in the US veteran population: results from the National Health and Resilience in Veterans Study.

  2014cited by this paper
• Prescribing Trends in Veterans With Posttraumatic Stress Disorder

  2013cited by this paper
• Prescribing trends in veterans with posttraumatic stress disorder.

  2012cited by this paper
• Pharmacological Stimulation of Locus Coeruleus Reveals a New Antipsychotic-Responsive Pathway for Deficient Sensorimotor Gating

  2011influential reference
• Prevalence and Axis I comorbidity of full and partial posttraumatic stress disorder in the United States: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions.

  2011cited by this paper
• Mutual independence of 5-HT2 and α1 noradrenergic receptors in mediating deficits in sensorimotor gating

  2011cited by this paper
• Noradrenergic and serotonergic mechanisms in the neurobiology of posttraumatic stress disorder and resilience.

  2009cited by this paper
• An Open-Label Study of Mirtazapine as Treatment for Combat-Related PTSD

  2009influential reference
• Anxiolytic-like profile of mirtazapine in rat conditioned fear stress model: Functional significance of 5-hydroxytryptamine 1A receptor and alpha1-adrenergic receptor.

  2009cited by this paper
• Meta-analytic review of event-related potential studies in post-traumatic stress disorder.

  2006influential reference
• Disruption of Prepulse Inhibition after Stimulation of Central but not Peripheral α-1 Adrenergic Receptors

  2006cited by this paper
• Locomotor hyperactivity induced by blockade of prefrontal cortical alpha2-adrenoceptors in monkeys.

  2005influential reference
• The effectiveness of mirtazapine in the treatment of post‐traumatic stress disorder: A 24‐week continuation therapy

  2005cited by this paper
• Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

  2005cited by this paper
• Yohimbine disrupts prepulse inhibition in rats via action at 5-HT1A receptors, not α2-adrenoceptors

  2005influential reference
• Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: A randomized open label trial

  2004cited by this paper
• Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial.

  2003influential reference
• Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms

  2003cited by this paper
• Effect of repeated treatment with mirtazapine on the central alpha1-adrenergic receptors.

  2002cited by this paper
• Effects of mirtazapine in patients with post‐traumatic stress disorder in Korea: a pilot study

  2002cited by this paper
• Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study.

  2002cited by this paper
• The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety.

  2001cited by this paper
• Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

  2001cited by this paper
• The α2A-Adrenergic Receptor Plays a Protective Role in Mouse Behavioral Models of Depression and Anxiety

  2001cited by this paper
• A pilot study of mirtazapine in post-traumatic stress disorder.

  1999influential reference
• Alpha-1-adrenergic receptors mediate sensorimotor gating deficits produced by intracerebral dizocilpine administration in rats.

  1999influential reference
• Psychotic features and illness severity in combat veterans with chronic posttraumatic stress disorder.

  1999cited by this paper
• Reduced sensory gating of the P1 potential in rape victims and combat veterans with posttraumatic stress disorder

  1999cited by this paper
• Responses to α2-adrenoceptor blockade by idazoxan in healthy male and female volunteers

  1997influential reference
• Mirtazapine: An Antidepressant with Noradrenergic and Specific Serotonergic Effects

  1997cited by this paper
• Responses to alpha 2-adrenoceptor blockade by idazoxan in healthy male and female volunteers.

  1997cited by this paper

• Mirtazapine and Depressions

  2020cites this paper
• Pharmacotherapy of 1,044 inpatients with posttraumatic stress disorder: current status and trends in German-speaking countries

  2020cites this paper
• Relationship between mirtazapine dose and incidence of adrenergic side effects: An exploratory analysis

  2019cites this paper
• Mirtazapine in combination with serotonin reuptake inhibitors improves depression and anxiety in patients with PTSD

  2018cites this paper